Patients | n=471 |

Age, median (range) | 33 (21–44) |

Nulliparous | 390 (83%) |

Histology | SCC: n=320 (68%) Adeno: n=146 (31%) AS: n=5 (1%) |

Stage (FIGO 2009) | IA1 (multifocal): n=8 (2%) IA1 with LVSI: n=43 (9%) IA2: n=92 (20%) IB1: n=321 (68%) IB2: n=5 (1%) IIA: n=2 |

Grading | G1: n=62 (13%) G2: n=313 (67%) G3: n=96 (20%) |

LVSI | Positive: n=146 (31%) Negative: n=325 (69%) |

Type of lymph node assessment | Sentinel: n=151 (32%) Complete LND: n=320 (68%) |

No of removed lymph nodes, median (range) | Sentinel: 7 (2-14) Complete: 19 (10-59) |

Residual tumor in trachelectomy specimen | Yes: n=136 (29%) No: n=335 (71%) |

Adjuvant therapy following RVT | n=29 (6%) Adjuvant chemotherapy: n=4 Adjuvant chemoradiation: n=12 Radical hysterectomy (±RCTX): n=13 |

Seeking motherhood | Yes: n=270/439 (62%) No: n=169/439 (38%) Not able due to adjuvant therapy: n=29 Lost to follow-up: n=3 |

Pregnancy rate | 196/270 (73%) 4 pregnancies: n=2 3 pregnancies: n=7 2 pregnancies: n=41 1 pregnancy: n=146 |

Fertility results | 205 live births Fetal weight (median): 2345 (680–4010) g 33 first trimester miscarriages 13 second trimester miscarriages 4 ongoing pregnancies 2 ectopic pregnancies |

Median follow-up (months) | 159 (2–312) Recurrences: n=16 (3.4%) Death: n=10 (2.1%) Death from other cause: n=2 (breast cancer, traffic accident) |

adeno, adenocarcinoma; AS, adenosquamous carcinoma; LND, lymph node dissection; LVSI, lymphovascular space invasion; RCTX, chemoradiation; RVT, radical vaginal trachelectomy; SCC, squamous cell carcinoma.